Article ; Online: Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment.
2022 Volume 13, Issue 1, Page(s) 5018
Abstract: mTORC1 is hyperactive in multiple cancer ... ...
Abstract | mTORC1 is hyperactive in multiple cancer types |
---|---|
MeSH term(s) | Endothelial Cells ; Humans ; Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors ; Midkine/metabolism ; Neoplasms/immunology ; Neoplasms/metabolism ; Neoplastic Stem Cells ; Sirolimus ; TOR Serine-Threonine Kinases ; Tuberous Sclerosis Complex 2 Protein ; Tumor Microenvironment ; Tumor Suppressor Proteins |
Chemical Substances | Tuberous Sclerosis Complex 2 Protein ; Tumor Suppressor Proteins ; Midkine (137497-38-2) ; MTOR protein, human (EC 2.7.1.1) ; Mechanistic Target of Rapamycin Complex 1 (EC 2.7.11.1) ; TOR Serine-Threonine Kinases (EC 2.7.11.1) ; Sirolimus (W36ZG6FT64) |
Language | English |
Publishing date | 2022-08-26 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 2553671-0 |
ISSN | 2041-1723 ; 2041-1723 |
ISSN (online) | 2041-1723 |
ISSN | 2041-1723 |
DOI | 10.1038/s41467-022-32673-7 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.